Author

Obinna Chijioke

University of ZurichORCID 0000-0003-4247-5947Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:differential expression· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Alberto BenguríaiD· 1 shared Álvaro F. García-JiméneziD· 1 shared Ana DopazoiD· 1 shared Andrea Sánchez de la Cruz· 1 shared Anne EugsteriD· 1 shared Arianna PicozziiD· 1 shared Benjamin KasendaiD· 1 shared Chantal PauliiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alberto BenguríaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PathologybioRxivPreprintJun 5, 2026

MTAP deficiency is a novel biomarker in neuroendocrine neoplasms of the lung

Magdalena M. Brune, Luca Roma, Nikolaus Deigendesch…·Lukas Bubendorf

The paper identifies MTAP deficiency as a biomarker in lung neuroendocrine neoplasms, distinguishing carcinoids from SCLC and LCNEC, and shows it is not caused by 9p21 deletion or promoter hypermethylation.

DOI 10.64898/2026.06.02.729487

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintOct 9, 2025

A high-resolution, unbiased analysis of the cellular immune response to Epstein-Barr virus

Álvaro F. García-Jiménez, Arianna Picozzi, Andrea Sánchez de la Cruz…·Hugh T. Reyburn

This study performs a single-cell transcriptomic analysis of EBV-responsive lymphocytes in healthy and immunodeficient individuals, identifying key immune mechanisms and potential therapeutic targets.

1 citation

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyHaematologicaPeer-reviewedSep 11, 2025

IGLV3-21-R110-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia

Claudia Fischer, Shih‐Shih Chen, Johanna Nimmerfroh…·Mascha Binder

This study develops bispecific antibodies targeting IGLV3-21R110 to selectively kill high-risk CLL cells while sparing healthy B cells and stem cells.

1 citation

humanproteomics

𝕏 PostBluesky